A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.
A continuation phase after the controlled part of a trial, where everyone knows they are receiving the compound. Useful for long-term safety, weak as efficacy evidence, because the blinding is gone.
Stay current
Free. We email when results are in, and nothing else.
Powered by MailerLite. No spam. Unsubscribe anytime.